GLEEVEC
Novartis AG
Application Filed: 2004-09-03
Trademark Application Details
REGISTERED AND RENEWED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78478393 |
| Registration Number | 3238831 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Novartis Pharmaceuticals Corporation |
| Attorney Name | Maury M. Tepper, III |
| Law Office Assigned | M20 |
| Employee Name | BELLO, ZACHARY R |
Timeline
| 2004-09-03 | Application Filed |
| 2005-12-20 | Published for Opposition |
| 2007-05-08 | Trademark Registered |
| 2017-04-15 | Location: GENERIC WEB UPDATE |
| 2017-04-15 | Status: Live/Registered |
| 2017-05-08 | Renewal Date |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Novartis AG |
| Address | CH-4002 Basel CH |
| Legal Entity Type | Corporation |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for [ the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in hematology, ] oncology [, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacterial-based disease, antivirals, antibiotics, and antifungals ] |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2004-09-13 | 1 NWAP I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2004-11-15 | 2 TCCA I:Incoming Correspondence |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2005-02-15 | 3 PARI I:Incoming Correspondence |
| APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2005-02-15 | 4 AMPX O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2005-03-10 | 5 DOCK D:Assigned to Examiner |
| PRIORITY ACTION WRITTEN | 2005-03-13 | 6 CPRA R:Renewal |
| PRIORITY ACTION E-MAILED | 2005-03-13 | 7 GPRA F:First Action |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2005-10-11 | 8 ABN2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2005-10-11 | 9 MAB2 O:Outgoing Correspondence |
| TEAS PETITION TO REVIVE RECEIVED | 2005-10-20 | 10 PROA I:Incoming Correspondence |
| PETITION TO REVIVE-GRANTED | 2005-10-20 | 11 PETG O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2005-10-20 | 12 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2005-10-20 | 13 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2005-10-24 | 14 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2005-10-24 | 15 CNSA P: |
| ASSIGNED TO LIE | 2005-10-28 | 16 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2005-11-01 | 17 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2005-11-30 | 18 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2005-12-20 | 19 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2006-03-14 | 20 NOAM O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2006-09-07 | 21 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2006-09-07 | 22 EXT1 S: |
| EXTENSION 1 GRANTED | 2006-09-07 | 23 EX1G S: |
| TEAS DELETE 1(B) BASIS RECEIVED | 2007-03-08 | 24 D1BR I:Incoming Correspondence |
| NOTICE OF ALLOWANCE CANCELLED | 2007-03-08 | 25 IUCN S: |
| 1(B) BASIS DELETED; PROCEED TO REGISTRATION | 2007-03-19 | 26 DP1B I:Incoming Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2007-05-08 | 27 R.PR A:Allowance for Publication |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-06-18 | 28 TCCA I:Incoming Correspondence |
| TEAS SECTION 8 & 15 RECEIVED | 2013-02-18 | 29 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2013-03-07 | 30 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2013-03-07 | 31 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2013-03-08 | 32 NA85 E:E-Mail |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2016-05-08 | 33 REM2 E:E-Mail |
| TEAS SECTION 8 & 9 RECEIVED | 2017-02-20 | 34 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2017-04-15 | 35 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2017-04-15 | 36 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2017-04-15 | 37 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2017-04-15 | 38 NA89 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 GLEEVEC 78478393 3238831 Live/Registered |
Novartis AG 2004-09-03 |
 GLEEVEC 78056665 2675047 Live/Registered |
Novartis AG 2001-04-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 